Study Stopped
Lack of ressources
The Antidepressant Effect of Right Prefrontal Low Frequency rTMS in an Accelerated Treatment Model
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Repetitive transcranial magnetic stimulation has appeared a new non-invasive antidepressant method, which implies non-convulsive focal stimulation of the prefrontal cortex of the brain through a time varying magnetic field. The method is associated with minimal side effects limited to local discomfort and especially no impact on cognitive function. The method has been approved for the treatment of depression in Canada, USA and a couple of European countries. The department for Affective Disorders, Aarhus University Hospital has used rTMS as add-on to conventional antidepressant treatment in the outpatient clinic since 2015. A single treatment course covers 20 sessions given on 20 consecutive days. The demand for daily treatment and attendance for 20 days is resource demanding for both the patient and the clinic. In consequence the investigators want to examine the antidepressant effect of an accelerated stimulus model comparing the outcome of the standard model ( 20 days) with a treatment model covering the same number of stimuli given within one week.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2019
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 7, 2019
CompletedFirst Posted
Study publicly available on registry
March 11, 2019
CompletedStudy Start
First participant enrolled
September 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2019
CompletedAugust 19, 2019
August 1, 2019
Same day
March 7, 2019
August 15, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Hamilton 17 item scale score for depression
A semistructured interview. On the basis of a systematic registration of well defined depressive symptoms through the preceding 3 days a total 17 item score and af 6-item subscale score expressing the degree of depression is calculated. The score is positively correlated to the degree af depression, Remission is defined as a total score after termination of treatment of \>= 8, response is defined by \>= 50% decrease in the total 17 item score during the treatment period
up to 4 weeks
Secondary Outcomes (1)
cognitive function
1 and 4 weeks
Study Arms (2)
rTMS standard
ACTIVE COMPARATORLow frequency (1 Hz), rTMS 20 sessions given on 20 consecutive days ( except weekends)
rTMS accelerated model
ACTIVE COMPARATORLow frequency ( 1 Hz), right prefrontal transcranial magnetic stimulation. 20 sessions given on 5 consecutive days ( 4 sessions each day)
Interventions
rTMS is a new non-invasive antidepressant method, which implies non-convulsive focal stimulation of the prefrontal cortex of the brain through a time varying magnetic field.
Eligibility Criteria
You may qualify if:
- Moderate-severe uni- and bipolar depression according to the International Classification of Diseases (ICD-10)
- A Hamilton scale score (HDS-17) of ≥ 18 and/or a sub-scale (HDSS) score of ≥ 9 within 24-48 hours before the first treatment
You may not qualify if:
- Organic brain disease.
- Epileptic seizure \< 2 years
- Patients with implanted metal parts in the brain or chest
- Patients with pacemaker
- Medical diseases with cerebral impact
- Serious suicidal danger
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Poul Erik Buchholtz, MD
Department of Depression and Anxiety
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Project collaborators examining the degree of depression during intervention are blinded to the type of treatment
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- senior researcher
Study Record Dates
First Submitted
March 7, 2019
First Posted
March 11, 2019
Study Start
September 1, 2019
Primary Completion
September 1, 2019
Study Completion
September 1, 2019
Last Updated
August 19, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share